Congressional Psychedelics Report Card: Who Supports and Opposes Legalization
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
Knowing which members of Congress will advance or block psychedelic medicine helps advocates know where to focus their energy.
Read More
Reunion Neuroscience announced that its drug luvesilocin received Breakthrough Therapy Designation for the treatment of postpartum depression.
Read More
The 5 best ketamine clinics in Baltimore (2026), verified for Johns Hopkins-trained physician, Avesta sister-clinic, IV+Spravato+KAP+TMS+NAD+ stack, and pricing —
Read More
The 3 best ketamine clinics in Chattanooga (2026), verified for anesthesia-trained KAP, REMS Spravato access, TMS, and pricing — with
Read More
They asked the agency to advance evaluations of rapid acting therapeutics for PTSD, traumatic brain injury and related conditions.
Read More
The DEA rules that power ketamine telemedicine expire December 31. The permanent rules will reshape platforms, prescribing, and referrals.
Read More
Most people who take a psychedelic under clinical supervision come through the session well. Some do not. A 2026 Stanford
Read More
A Center for Health Care Strategies report examines how psychedelic-assisted therapy could reach Medicaid. Some states already cover off-label IV
Read More
Anxiety shows up as racing heart, shortness of breath, stomach knots, looping thoughts, and sleep disruption. Plus clinical subtypes and
Read More
How Healing REIT, a Real Estate Investment Trust (REIT) is revolutionizing psychedelic therapy and mental health
Read More